Categories News BioNTech confident COVID-19 vaccine effective against new UK mutation Post author By Post date 12/21/2020 BioNTech Chief Executive Ugur Sahin said on Monday he was confident a COVID-19 vaccine co-developed by his company would be effective against a variant of the virus that has emerged in Britain. Read More ← CDC issues guidelines on COVID-19 vaccination after reactions from people with history of allergies → Waterloo Region receives first COVID-19 vaccines ahead of schedule